UMIN-CTR Clinical Trial

Basic information
Public title	Verification of the effect of consumption of food containing plant extract on fat consumption. A placebo-controlled, randomized, double-blind, cross-over trial.
Acronym	Verification of the effect of consumption of food containing plant extract on fat consumption.
Scientific Title	Verification of the effect of consumption of food containing plant extract on fat consumption. A placebo-controlled, randomized, double-blind, cross-over trial.
Scientific Title:Acronym	Verification of the effect of consumption of food containing plant extract on fat consumption.
Region	Japan

Condition
Condition	Healthy volunteers
Classification by specialty	Endocrinology and Metabolism Adult
Classification by malignancy	Others
Genomic information	NO

Objectives
Narrative objectives1	To evaluate the effects of intake of plants extract on promoting fat consumption at rest.
Basic objectives2	Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes	Respiratory quotient
Key secondary outcomes	Energy consumption Oxygen consumption Lipid oxidation Carbohydrate oxidation

Base
Study type	Interventional

Study design
Basic design	Cross-over
Randomization	Randomized
Randomization unit	Individual
Blinding	Double blind -all involved are blinded
Control	Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms	2
Purpose of intervention	Prevention
Type of intervention	Food
Interventions/Control_1	Test food with plants extract - washout period - placebo food
Interventions/Control_2	Placebo food - washout period - test food with plants extract
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit	20 years-old <=
Age-upper limit	60 years-old >
Gender	Male
Key inclusion criteria	(1)Males and Females from 20 to 59 years of age(from 20 to 30 kg/m2) (2) Subjects giving written informed consent
Key exclusion criteria	(1)Individuals who cannot stop the consumption of health foods (including foods for specified health uses and foods with functional claims) and medicines that affect carbohydrate metabolism, lipid metabolism, and body fat (2)Individuals who may develop allergies related to the test (3) Smoker (4)Individuals who have high blood pressure, cardiovascular disease, diabetes, endocrine disease (5)Individuals who have had drug dependence or alcohol dependence in the past or present (6)Individuals who participate in tests that consume other foods or use drugs, who participate in tests that apply cosmetics, drugs, or who are willing to participate (7)Individuals judged by the investigator or investigator to be inappropriate for participation in the study
Target sample size	15

Research contact person
Name of lead principal investigator	1st name Tomonori Middle name Last name Ando
Organization	Lotte Co., Ltd.
Division name	Central Laboratory , Food material development section
Zip code	336-8601
Address	1-1, Numakage-3chome, Minami-ku, Saitama
TEL	048-837-0187
Email	andou_tomonori@lotte.co.jp

Public contact
Name of contact person	1st name Tomonori Middle name Last name Ando
Organization	Lotte Co., Ltd.
Division name	Central Laboratory , Food material development section
Zip code	336-8601
Address	1-1, Numakage-3chome, Minami-ku, Saitama
TEL	048-837-0187
Homepage URL
Email	andou_tomonori@lotte.co.jp

Sponsor
Institute	Lotte Co., Ltd.
Institute
Department

Funding Source
Organization	Lotte Co., Ltd.
Organization
Division
Category of Funding Organization	Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization	Shiba Palace Clinic institutional review board
Address	6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan
Tel	03-5408-1590
Email	jimukyoku@mail.souken-r.com

Secondary IDs
Secondary IDs	NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information	2020 Year 01 Month 29 Day

Related information
URL releasing protocol
Publication of results	Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled	14
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status	Completed
Date of protocol fixation	2020 Year 01 Month 23 Day
Date of IRB	2020 Year 01 Month 23 Day
Anticipated trial start date	2020 Year 01 Month 30 Day
Last follow-up date	2020 Year 03 Month 31 Day
Date of closure to data entry	2020 Year 04 Month 03 Day
Date trial data considered complete	2020 Year 04 Month 08 Day
Date analysis concluded	2020 Year 04 Month 10 Day

Other
Other related information

Management information
Registered date	2020 Year 01 Month 29 Day
Last modified on	2021 Year 03 Month 17 Day

Link to view the page
URL(English)	https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000044828